“…In the scientific research field, initiatives that seek to assess other agents may soon help to alleviate the dilemma of loss reduction versus long-term effects of antipsychotics. Thence, the relevance of the Okamoto et al 5 study is identified in this number. The researchers conducted a study in rat models of schizophrenia to analyse the possibility of beneficial effects of ascorbic acid in schizophrenia.…”